RadNet (RDNT) Small-Cap Growth Virtual Investor Conference summary

Company overview and industry context

• Largest owner-operator of fixed-site diagnostic imaging centers in the US, operating 375 locations across eight states with over 10,000 employees.

• Industry is highly fragmented, with hospitals still performing 40%-50% of imaging; shift toward outpatient centers is accelerating due to cost advantages.

• Geographic concentration in populous states enables operational efficiencies and strong negotiating power with payors.

• Multimodality strategy offers a full range of imaging services, driving both volume and margin.

• M&A and joint ventures with major health systems are key growth drivers, with 137 locations in joint ventures.

Financial performance and growth strategy

• Projected 2024 revenue between $1.7B and $1.8B, with EBITDA near $275M, reflecting strong organic and acquisition-driven growth.

• Organic same-store volume growth in the mid-single digits, with EBITDA growth exceeding 10% and expanding margins.

• Recent expansion into Houston through acquisitions, with plans to open 12 new centers in 2024 and more in 2025.

• Over $700M in cash and recently refinanced debt to 2031, lowering cost of capital and supporting future growth.

• Net operating loss carryforward will reduce federal tax burden for several years.

Revenue mix and payer relationships

• Commercial insurance accounts for over 58% of revenue, Medicare 21.7%, and capitation 8%.

• Capitation agreements with over 30 medical groups, mainly in California, provide stable, long-term revenue and drive additional fee-for-service business.

• Advanced imaging (MRI, CT, PET CT) represents 25.5% of volume but drives about 60% of revenue, with a trend toward higher-margin advanced modalities.

• Joint ventures with major health systems boost volumes and help secure favorable payor contracts.